Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.

"Exelixis and MSD to trial cancer therapies together in clinical collaboration" was originally created and published by ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

Just how much pain do you have to endure to benefit from weight training? Fitness experts say that depends on what you’re trying to accomplish. For years, some trainers have ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...

Exelixis, an Alameda, Calif., oncology company, and Rahway, N.J., drugmaker Merck said they also plan a Phase 1/2 trial and two Phase 3 studies of zanzalintinib in combination with Merck's Welireg in ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Dutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start clinical trials of its lead drug candidate INT-1B3 for solid tumours.

The Canadian government is looking into the dough-like substance that is appearing on beaches in the province. The dazzling spectacle on Thursday night was the strongest since May. The government ...

Genaro García Luna is the highest-ranking Mexican official ever to be convicted in the US. The rural area, which is plagued by violence, is largely under the control of the powerful Jalisco New ...